Imexpharm Corp - Asset Resilience Ratio

Latest as of June 2026: 11.76%

Imexpharm Corp (IMP) has an Asset Resilience Ratio of 11.76% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Imexpharm Corp (IMP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₫346.67 Billion

≈ $13.17 Million USD Cash + Short-term Investments

Total Assets

₫2.95 Trillion

≈ $111.96 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Imexpharm Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Imexpharm Corp balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Imexpharm Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Imexpharm Corp for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₫0.00	0%
Short-term Investments	₫346.67 Billion	11.76%
Total Liquid Assets	₫346.67 Billion	11.76%

Asset Resilience Insights

Moderate Liquidity: Imexpharm Corp has 11.76% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Imexpharm Corp Industry Peers by Asset Resilience Ratio

Compare Imexpharm Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Imexpharm Corp (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Imexpharm Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.62%	₫212.10 Billion ≈ $8.06 Million	₫2.78 Trillion ≈ $105.72 Million	+1.95pp
2024-12-31	5.67%	₫142.00 Billion ≈ $5.40 Million	₫2.50 Trillion ≈ $95.17 Million	+1.78pp
2023-12-31	3.89%	₫93.00 Billion ≈ $3.53 Million	₫2.39 Trillion ≈ $90.90 Million	-5.39pp
2022-12-31	9.28%	₫211.30 Billion ≈ $8.03 Million	₫2.28 Trillion ≈ $86.51 Million	+4.38pp
2021-12-31	4.90%	₫112.45 Billion ≈ $4.27 Million	₫2.29 Trillion ≈ $87.18 Million	+1.87pp
2020-12-31	3.03%	₫63.61 Billion ≈ $2.42 Million	₫2.10 Trillion ≈ $79.65 Million	+2.75pp
2019-12-31	0.28%	₫5.19 Billion ≈ $197.09K	₫1.85 Trillion ≈ $70.18 Million	--

pp = percentage points

About Imexpharm Corp

VN:IMP Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$221.77 Million

₫5.84 Trillion VND

Market Cap Rank

#16235 Global

#88 in Vietnam

Share Price

₫37900.00

Change (1 day)

+4.70%

52-Week Range

₫35000.00 - ₫56700.00

All Time High

₫97000.00